publication . Article . 2016

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION

Yu. B. Belousov; I. S. Yavelov; D. Yu. Belousov; E. V. Afanasieva;
Open Access
  • Published: 01 Jan 2016 Journal: Rational Pharmacotherapy in Cardiology, volume 7, pages 561-566 (issn: 1819-6446, eissn: 2225-3653, Copyright policy)
  • Publisher: Stolichnaya Izdatelskaya Kompaniyaizdat
Abstract
Aim. To analyze the structure of expenses associated with warfarin dose adjustment and international normalized ratio (INR) control for patients with atrial fibrillation (AF) per 1 year of treatment. Material and methods. AF prevalence rate was calculated according to the large population studies data. The study was performed based on methodology for Cost of Illness evaluation. Expenses associated with INR monitoring within the obligatory medical insurance program were calculated based on the general tariff agreement for 2011 year for one of the territorial subject of Russia. Expenses associated with INR monitoring in outpatient departments of university clinics...
Subjects
Medical Subject Headings: cardiovascular diseases
free text keywords: atrial fibrillation, warfarin, the cost of illness, lcsh:Therapeutics. Pharmacology, lcsh:RM1-950, lcsh:Diseases of the circulatory (Cardiovascular) system, lcsh:RC666-701
Any information missing or wrong?Report an Issue